176 related articles for article (PubMed ID: 17705297)
21. Acute onset autoimmune hepatitis: Clinical presentation and treatment outcomes.
Aljumah AA; Al-Ashgar H; Fallatah H; Albenmousa A
Ann Hepatol; 2019; 18(3):439-444. PubMed ID: 31040094
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin.
Zolfino T; Heneghan MA; Norris S; Harrison PM; Portmann BC; McFarlane IG
Gut; 2002 May; 50(5):713-7. PubMed ID: 11950822
[TBL] [Abstract][Full Text] [Related]
23. Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
Mohamadnejad M; Malekzadeh R; Nasseri-Moghaddam S; Hagh-Azali S; Rakhshani N; Tavangar SM; Sedaghat M; Alimohamadi SM
Dig Dis Sci; 2005 Mar; 50(3):547-51. PubMed ID: 15810640
[TBL] [Abstract][Full Text] [Related]
24. Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Martínez Casas OY; Díaz Ramírez GS; Marín Zuluaga JI; Santos Ó; Muñoz Maya O; Donado Gómez JH; Restrepo Gutiérrez JC
Gastroenterol Hepatol; 2018 Nov; 41(9):544-552. PubMed ID: 30017212
[TBL] [Abstract][Full Text] [Related]
25. Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment.
Soares JC; Borgonovo A; Maggi DC; Pasinato AP; Ramos FG; Dantas-Corrêa EB; Schiavon LL; Narciso-Schiavon JL
Minerva Gastroenterol Dietol; 2016 Jun; 62(2):138-47. PubMed ID: 27091035
[TBL] [Abstract][Full Text] [Related]
26. Clinical features and management of autoimmune hepatitis.
Krawitt EL
World J Gastroenterol; 2008 Jun; 14(21):3301-5. PubMed ID: 18528927
[TBL] [Abstract][Full Text] [Related]
27. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
28. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
[TBL] [Abstract][Full Text] [Related]
29. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.
Ozaslan E; Efe C; Heurgué-Berlot A; Kav T; Masi C; Purnak T; Muratori L; Ustündag Y; Bresson-Hadni S; Thiéfin G; Schiano TD; Wahlin S; Muratori P
Clin Gastroenterol Hepatol; 2014 May; 12(5):863-9. PubMed ID: 24076417
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and pathological characteristics and outcome of 46 children with autoimmune hepatitis].
Cao LL; Zhang M; Zhu SS; Dong Y; Xu ZQ; Chen DW; Wang LM; Wang FC; Gan Y; Yan JG; Wang P; Li AQ
Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):40-45. PubMed ID: 30630230
[No Abstract] [Full Text] [Related]
32. Long-term outcome of Japanese patients with type 1 autoimmune hepatitis.
Yoshizawa K; Matsumoto A; Ichijo T; Umemura T; Joshita S; Komatsu M; Tanaka N; Tanaka E; Ota M; Katsuyama Y; Kiyosawa K; Abe M; Onji M
Hepatology; 2012 Aug; 56(2):668-76. PubMed ID: 22334246
[TBL] [Abstract][Full Text] [Related]
33. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
Kerkar N; Yanni G
J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune Hepatitis in Children.
Pathak S; Kamat D
Pediatr Ann; 2018 Feb; 47(2):e81-e86. PubMed ID: 29446799
[TBL] [Abstract][Full Text] [Related]
35. Fulminant presentation of autoimmune hepatitis: clinical features and early predictors of corticosteroid treatment failure.
Mendizabal M; Marciano S; Videla MG; Anders M; Zerega A; Balderramo DC; Tisi Baña MR; Barrabino M; Gil O; Mastai R; Yantorno S; Gadano A; Silva MO
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):644-8. PubMed ID: 25923939
[TBL] [Abstract][Full Text] [Related]
36. Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis.
Abe K; Katsushima F; Kanno Y; Takahashi A; Yokokawa J; Ohira H; Arinaga T; Ide T; Nishimura J; Inoue M; Seike M; Imazeki F; Yokosuka O; Sata M
Intern Med; 2012; 51(24):3323-8. PubMed ID: 23257515
[TBL] [Abstract][Full Text] [Related]
37. Possible benefit of splenectomy in liver transplantation for autoimmune hepatitis.
Xu YT; Liu DJ; Meng FY; Li GB; Liu J
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):328-31. PubMed ID: 24919618
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune hepatitis in India: single tertiary referral centre experience.
Amarapurkar D; Dharod M; Amarapurkar A
Trop Gastroenterol; 2015; 36(1):36-45. PubMed ID: 26591953
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune hepatitis: Single-center experience of clinical presentation, response to treatment and prognosis in Saudi Arabia.
Fallatah HI; Akbar HO; Qari YA
Saudi J Gastroenterol; 2010; 16(2):95-9. PubMed ID: 20339178
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune paediatric liver disease.
Mieli-Vergani G; Vergani D
World J Gastroenterol; 2008 Jun; 14(21):3360-7. PubMed ID: 18528933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
